MarketPeel
Insider Trading Intelligence
WD

William F. Doyle

NVCR
EXECUTIVE CHAIRMAN · NOVOCURE LTD · CIK 0001194459
FILING MIX · LIFETIME38%/62%
BUYS
27
SELLS
44
TOTAL VALUE
$66.59M
COMPANIES
4
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
632,283
AVG SELL PX
$93.48
TRADE KIND
SHOWING 71 / 71
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
39 backtested trades · 8 horizons · 6 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by William F. Doyle, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d39+87.18%-1.33%-0.24%-1.10%-1.09%-2.18
14d39+30.77%+5.28%+0.61%+4.67%+6.56%3.25
30d39+74.36%-5.07%+0.90%-5.98%-11.69%-3.05
60d39+20.51%+6.28%+2.32%+3.95%+6.83%1.67
90d39+69.23%+4.43%+6.12%-2.96%-9.15%-1.02
180d39(2 pending)+67.57%-13.17%+8.10%-21.27%-49.47%-2.84
1y39(2 pending)+67.57%-1.09%+15.89%-16.98%-64.81%-1.28
2y39(2 pending)+86.49%-45.16%+16.69%-61.85%-70.30%-16.98
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NVCR · 400,284 shares · as of Mar 3, 2026
0178,298356,597534,895713,193202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 27 buys / 44 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PROK
PROKIDNEY CORP.
PURCHASEGRANT
Stock grant
135,000135,000May 28, 2026May 29, 2026View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
200,000200,000Mar 3, 2026Mar 5, 2026View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
30,072288,517Mar 3, 2026Mar 5, 2026View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
50,557$12.79$646.4K349,727Mar 3, 2026Mar 5, 2026View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
258,445258,445Mar 3, 2026Mar 5, 2026View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
21,330$13.43$286.4K328,397Mar 3, 2026Mar 5, 2026View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
200,284400,284Mar 3, 2026Mar 5, 2026View →
PROK
PROKIDNEY CORP.
PURCHASEGRANT
Stock grant
125,862125,862May 29, 2025Jun 2, 2025View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASEGRANT
Stock grant
18,16994,499Nov 29, 2024Dec 3, 2024View →
PROK
PROKIDNEY CORP.
PURCHASEGRANT
Stock grant
62,55862,558May 30, 2024Jun 3, 2024View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASE
15,000$16.98$254.7K76,330May 21, 2024May 23, 2024View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASE
15,000$16.30$244.5K61,330Mar 8, 2024Mar 12, 2024View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASEGRANT
Stock grant
20,37446,330Nov 30, 2023Dec 4, 2023View →
PROK
PROKIDNEY CORP.
PURCHASEGRANT
Stock grant
48,12848,128Jun 29, 2023Jul 3, 2023View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASEGRANT
Stock grant
18,64925,956Nov 30, 2022Dec 2, 2022View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
837$69.66$58.3K551,176Aug 2, 2022Aug 3, 2022View →
PROK
PROKIDNEY CORP.
PURCHASEGRANT
Stock grant
1,514,3261,514,326Jul 11, 2022Jul 13, 2022View →
PROK
PROKIDNEY CORP.
PURCHASEGRANT
Stock grant
1,514,3261,514,326Jul 11, 2022Jul 13, 2022View →
NERV
MINERVA NEUROSCIENCES, INC.
PURCHASEGRANT
Stock grant
2,5002,500Jun 10, 2022Jun 28, 2022View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
2,385$70.10$167.2K552,013Mar 8, 2022Mar 9, 2022View →
NVCR
NOVOCURE LTD
PURCHASEGRANT
Stock grant
14,581$80.59$1.18M14,581Mar 3, 2022Mar 7, 2022View →
ELAN
ELANCO ANIMAL HEALTH INC
PURCHASEGRANT
Stock grant
7,3077,307Nov 30, 2021Dec 2, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
995$149.38$148.6K554,398Aug 2, 2021Aug 4, 2021View →
NERV
MINERVA NEUROSCIENCES, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jun 11, 2021Jun 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
1,500$213.35$320.0K556,493Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
500$214.67$107.3K555,993Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
4,388$202.16$887.1K573,225Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
4,125$201.55$831.4K577,613Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
24,338$197.00$4.79M610,251Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
4,500$207.80$935.1K561,314Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
8,814$196.07$1.73M634,589Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
521$210.18$109.5K558,593Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
1,900$192.52$365.8K647,093Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
1,284$206.35$265.0K565,814Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
600$211.28$126.8K557,993Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
2,090$193.57$404.6K645,003Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
1,400$191.26$267.8K648,993Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
600$216.69$130.0K555,393Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
1,600$205.43$328.7K567,098Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
4,338$199.71$866.4K581,738Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
1,600$194.94$311.9K643,403Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
13,612$197.83$2.69M596,639Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
1,972$204.28$402.8K568,698Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
2,200$209.34$460.6K559,114Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
2,555$203.25$519.3K570,670Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
10,563$198.98$2.10M586,076Apr 13, 2021Apr 15, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
7,928$134.12$1.06M650,393Apr 1, 2021Apr 2, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
9,2590Mar 31, 2021Apr 2, 2021View →
NVCR
NOVOCURE LTD
PURCHASE
Executive Chairman
9,259$125.25$1.16M658,321Mar 31, 2021Apr 2, 2021View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
896$76.39$68.4K649,062Jul 31, 2020Aug 3, 2020View →
NERV
MINERVA NEUROSCIENCES, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jun 11, 2020Jun 12, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
31,332$63.73$2.00M649,958May 11, 2020May 12, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
58,7670May 8, 2020May 11, 2020View →
NVCR
NOVOCURE LTD
PURCHASE
Executive Chairman
58,767$63.84$3.75M713,193May 8, 2020May 11, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
31,903$63.50$2.03M681,290May 8, 2020May 11, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
58,76858,767May 7, 2020May 11, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
30,993$64.74$2.01M654,426May 7, 2020May 11, 2020View →
NVCR
NOVOCURE LTD
PURCHASE
Executive Chairman
58,768$64.77$3.81M685,419May 7, 2020May 11, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
58,768117,535May 6, 2020May 7, 2020View →
NVCR
NOVOCURE LTD
PURCHASE
Executive Chairman
58,768$64.15$3.77M626,651May 6, 2020May 7, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
29,881$64.27$1.92M567,883May 6, 2020May 7, 2020View →
NVCR
NOVOCURE LTD
PURCHASE
Executive Chairman
58,768$61.40$3.61M628,047May 5, 2020May 7, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
58,768176,303May 5, 2020May 7, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
30,283$62.47$1.89M597,764May 5, 2020May 7, 2020View →
NVCR
NOVOCURE LTD
PURCHASE
Executive Chairman
58,768$60.48$3.55M569,279May 4, 2020May 6, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
58,768235,071May 4, 2020May 6, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
4,320$69.53$300.4K510,511Mar 6, 2020Mar 10, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
3,893$72.22$281.1K514,831Feb 28, 2020Mar 2, 2020View →
NVCR
NOVOCURE LTD
PURCHASE
Executive Chairman
9,259$79.45$735.6K518,724Feb 27, 2020Mar 2, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
9,2599,259Feb 27, 2020Mar 2, 2020View →
NVCR
NOVOCURE LTD
SALE
Executive Chairman
133,777$95.00$12.71M509,465Jan 17, 2020Jan 22, 2020View →
Other insiders · NVCR
Loading peer insiders…
About this filer
CIK 0001194459
ROLE
Executive Chairman
PRIMARY
NVCR
COMPANIES
4
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001194459DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback